Cardiac resynchronization therapy (CRT) is a treatment of proven efficacy for selected
patients with heart failure and associated conduction disturbances. The increasing financial …

Cost-effectiveness estimates can help optimize use of available financial resources and this
is especially relevant for implementation of cardiac resynchronization therapy (CRT), given …

Objectives Cardiac resynchronization therapy with a biventricular pacemaker (CRT-P) is an
effective treatment for dyssynchronous heart failure (DHF). Adding an implantable …

Aims Cardiac resynchronization therapy (CRT-P) is an effective treatment for patients with
heart failure and cardiac dyssynchrony with moderate or severe symptoms despite …

Supported by extensive clinical evidence, electrical device therapy for heart failure has had
impressive development during the last 15 years. Patients with chronic heart failure (CHF) …

Recent studies have provided the impetus to update the recommendations for cardiac
resynchronization therapy (CRT). This article provides guidance on the implementation of …

Background Cardiac resynchronisation therapy (CRT) is a well-established form of treatment
for patients with heart failure and cardiac dyssynchrony. There are two different types of CRT …

Within the last decade, cardiac resynchronization therapy (CRT) has evolved rapidly and is
today widely accepted as a class I indication for selected patients with heart failure. 1, 2 It is …

Abstract Aims Whilst the CArdiac REsynchronization in Heart Failure (CARE-HF) trial has
shown that cardiac resynchronization therapy (CRT) leads to reduced morbidity and …

Large randomized controlled trials have demonstrated that cardiac resynchronization
therapy (CRT) improves morbidity and mortality in patients with moderate to severe heart …